Molecular subtypes explain lupus epigenomic heterogeneity unveiling new regulatory genetic risk variants NPJ Genom Med
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance J Clin Oncol
Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma J Clin Invest
Low dose lenalidomide versus placebo in non-transfusion dependent patients with low risk, del(5q) myelodysplastic syndromes (SintraREV): a randomised, double-blind, phase 3 trial Lancet Haematol
The effects of ENDOG on lipid metabolism may be tissue-dependent and may not require its translocation from mitochondria Nat Commun
NF-κB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment Sci Adv
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial Lancet Haematol